×
News Home

Where Does Checkpoint Therapeutics Inc (CKPT) Stock Fall in the Biotechnology Field After It Has Fallen -14.73% This Week?

Monday, December 06, 2021 10:29 AM | InvestorsObserver Analysts
Where Does Checkpoint Therapeutics Inc (CKPT) Stock Fall in the Biotechnology Field After It Has Fallen -14.73% This Week?

The 51 rating InvestorsObserver gives to Checkpoint Therapeutics Inc (CKPT) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 79 percent of stocks in the Biotechnology industry, CKPT’s 51 overall rating means the stock scores better than 51 percent of all stocks.

Overall Score - 51
CKPT has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on CKPT!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Checkpoint Therapeutics Inc Stock Today?

Checkpoint Therapeutics Inc (CKPT) stock is trading at $2.72 as of 10:25 AM on Monday, Dec 6, a gain of $0.02, or 0.74% from the previous closing price of $2.70. The stock has traded between $2.61 and $2.83 so far today. Volume today is light. So far 247,275 shares have traded compared to average volume of 1,123,756 shares. Click Here to get the full Stock Report for Checkpoint Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App